<!DOCTYPE html>
<html>
<head><title>Medicines for pcod and pcos</title></head>
<center><h1>MEDICINES FOR PCOD and PCOS</h1></center>
<h1><b>1.Hyponidd tablet</h1></b>
<p>Hyponidd as the best ayurvedic medicine for PCOS improves ovulatory function and corrects several metabolic derangements associated with insulin resistance. 
Hyponidd decreases the insulin, and thereby corrects the three axes, namely: metabolic, reproductive and steroidogenic.
it helps to reduce weight.
it will regulate hormones.
</p>
<center><img src=https://www.charak.com/wp-content/uploads/2020/07/HYPONIDD-CAROUSELS_FINAL-1-1-300x300.jpg></center>
<h1><b>2.Clomiphene</h1></b>
<p>Clomiphene is usually the first treatment recommended for women with PCOS who are trying to get pregnant. Clomifene encourages the monthly release of an egg from the ovaries (ovulation).
Clomiphene is in a class of medications called ovulatory stimulants. It works similarly to estrogen, a female hormone that causes eggs to develop in the ovaries and be released.
This medication is not recommended for women whose ovaries no longer make eggs properly (primary pituitary or ovarian failure).
An increased level of FSH hormones improves the chances of growing an ovarian follicle that can then trigger ovulation. In women who ovulate irregularly, approximately 80 percent who take clomiphene will ovulate and 30 to 40 percent of all women who take clomiphene <b>become pregnant</b>.</p>
<center><img src=https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRx2qZ45yCJhyD9Y2Ks9q3GBtm4oCeUgOyPiA&usqp=CAU-400x400></center>
<h1><b>3.Letrozole</h1></b>
<p>Letrozole is an aromatase inhibitor used to induce ovulation in patients with irregular menses or no menses at all. Letrozole works to induce ovulation by blocking estrogen production, leading to increases in follicle-stimulating hormone (FSH) release.
Research shows that Letrozole is effective at inducing ovulation in women with PCOS. Due to similar success rates and lower chance of side effects, letrozole is now the preferred first-line medication for PCOS.
 <h3>Dosage for Letrozole</h3>
 <p>Letrozole at the dose of 5.0 mg/day produces higher pregnancy rate and more mature follicles in fertile women with PCOS.</p>
<center><img src=data:image/jpeg;base64,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></center>
<h1><b>4.Metphormin</h1></b>
<p>Metformin is an effective ovulation induction agent for non-obese women with PCOS and offers some advantages over other first line treatments for anovulatory infertility such as clomiphene. For clomiphene-resistant women, metformin alone or in combination with clomiphene is an effective next step.
Metformin works as a treatment for PCOS by enhancing the body's sensitivity to insulin. This decreases the levels of circulating insulin and also produces a positive effect on adipose (fat) tissue. Doctors traditionally recommend metformin as a PCOS treatment for women who have a raised BMI (body mass index).
Daily Metformin for 2 Years, But Most Benefit Seen in First 6 Months.
 Weight loss is a feature of protracted metformin therapy in obese women with PCOS, with greater weight reduction potentially achievable with higher doses. 
  <h3>Dosage for Metphormin</h3>
The starting dose for adults with PCOS is 500 mg once a day. Your doctor will increase your dose slowly over a few weeks. This allows your body to get used to the medicine and reduces side effects. The usual dose is 1500–1700 mg per day.
<center><img src=https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQi7BaqD1nyhkGH9vjOcnJ99Q-hMvR4JqNAig&usqp=CAU></center>
<h1><b>5.Spironolactone</h1></b>
<p>Spironolactone (brand name Aldactone) is a prescription diuretic (“water pill”) commonly used to treat heart failure. It can also help with the symptoms of polycystic ovary syndrome (PCOS), primarily excessive hair growth.
Spironolactone, the generic name for Aldactone,works by blocking the effects of androgen. Androgens are hormones that both males and females have, but males have higher levels of them. Androgens such as testosterone are responsible for hair growth on the face, chest, and stomach that some young women with PCOS have.
In PCOS patients, spironolactone is still effective for reducing hirsutism; however, for treatment of the hormonal or metabolic manifestations associated with PCOS, it may be necessary to combine spironolactone with either an antigonadotrophic agent or a drug that improves peripheral insulin sensitivity.
Both birth control pills and anti-androgens like spironolactone (usually prescribed to reduce blood pressure) tend to lead to weight loss, which is a very appealing side effect.
 Spironolactone in the treatment of hirsutism, menstrual cycle frequency, and hormonal derangements and is associated with fewer adverse events.
   <h3>Dosage for Spironolactone</h3>
   It is best to take your dose early in the day (before 6 p.m.) to prevent having to get up during the night to urinate. 
    Long test: 400 mg orally once/day for 3-4 weeks
    Short test: 400 mg orally once/day for 4 days
<center><img src=https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSk5Etb-OScN1jzdAVxFCCVTF14oI6XWOdyqQ&usqp=CAU></center>
<h1><b>6.Eflornithine(vaniqa)</h1></b>
<p>
It is very important that you see your doctor, and get good advice and support about managing your PCOS , including help with weight loss/weight management. As Vaniqa works at the level of the hair follicle it can be safely continued alongside any other treatment.</p>
<p align="right">
<a href="timer.html" class="button">GO BACK</a></p>
</html>





